Twinaqt (Dolutegravir/Lamivudine)
| Active Ingredient | Dolutegravir/Lamivudine |
|---|---|
| Indication: | HIV infection |
| Manufacturer: | Emcure Pharmaceuticals Ltd. |
| Packaging | 30 Tablets in bottle |
| Strength | 350mg |
| Delivery Time | 6 To 15 days |
Twinaqt is a two-drug, once-daily antiretroviral combination tablet that contains Dolutegravir and Lamivudine. It is used for the treatment of HIV-1 infection in adults and adolescents weighing at least 40 kg who have no known or suspected resistance to either drug.
Dolutegravir is an integrase strand transfer inhibitor (INSTI) that blocks the integration of viral DNA into human DNA, stopping HIV replication.
Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) that inhibits the reverse transcriptase enzyme, also preventing the virus from multiplying.
Twinaqt offers a simplified two-drug regimen that is effective, well-tolerated, and reduces long-term medication exposure while maintaining viral suppression.








There are no reviews yet.